Clinical Trial Update: Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating FDG-PET based cell proliferation in pulmonary hypertension, comparing patients to healthy subjects; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: Joan Albert Barbera Mir | Conditions: Pulmonary Hypertension | Phase 1, Phase 2 | Status: COMPLETED